Oka strain varicella vaccine
GPTKB entity
Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
live attenuated vaccine |
| gptkbp:administeredBy |
injection
|
| gptkbp:approvedBy |
gptkb:Europe
gptkb:Japan gptkb:United_States |
| gptkbp:broadcastOn |
2 doses
|
| gptkbp:contains |
live attenuated varicella-zoster virus
|
| gptkbp:contraindication |
pregnancy
immunocompromised individuals |
| gptkbp:developedBy |
gptkb:Japan
gptkb:Michiaki_Takahashi Oka strain of varicella-zoster virus |
| gptkbp:firstLicensed |
1974
|
| https://www.w3.org/2000/01/rdf-schema#label |
Oka strain varicella vaccine
|
| gptkbp:indication |
children
adults without immunity |
| gptkbp:marketedAs |
gptkb:Varilrix
gptkb:Merck_&_Co. gptkb:Varivax GlaxoSmithKline |
| gptkbp:prevention |
gptkb:varicella
gptkb:chickenpox herpes zoster |
| gptkbp:routeOfAdministration |
subcutaneous
|
| gptkbp:sideEffect |
fever
injection site reaction mild rash |
| gptkbp:storage |
2-8°C
|
| gptkbp:usedIn |
childhood immunization
|
| gptkbp:WHOModelListOfEssentialMedicines |
included
|
| gptkbp:bfsParent |
gptkb:Michiaki_Takahashi
|
| gptkbp:bfsLayer |
7
|